Skip to main content
EIKN logo

EIKN · Eikon Therapeutics, Inc. · Debt

Track EIKN — free
$5.90 +0.06 (+1.03%) At close · Nov 6
Market Cap
$319.57M
Shares
54.17M
Volume · Nov 6 402.39K Avg daily vol (3M) 576.61K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Finance lease liabilities 2026-06-30 USD 0 10-Q filed 2026-08-13
Operating lease liabilities 2026-06-30 USD 252,219,000 10-Q filed 2026-08-13
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 9,445,000
Noncurrent operating lease liabilities
USD 242,774,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1861123 CUSIP 282564103 13F (30d) 28 filings 28 filers Visit website Investor relations